Shachi Srivatsa

Dr. Shachi Srivatsa

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
SSShachi Srivatsa
Shachi Srivatsa
LGLindsay Gil
Lindsay Gil
YZYueran Zhang
Yueran Zhang
BRBeth Rymeski
Beth Rymeski
AGAmelia Gavulic
Amelia Gavulic
JAJennifer H. Aldrink
Jennifer H. Aldrink

19 June 2025 in International Journal of Cancer
Verified
Journal Article
Closed access
SSShachi Srivatsa
Shachi Srivatsa
LGLindsay Gil
Lindsay Gil
YZYueran Zhang
Yueran Zhang
BRBeth Rymeski
Beth Rymeski
AGAmelia Gavulic
Amelia Gavulic
JAJennifer H. Aldrink
Jennifer H. Aldrink

28 April 2025 in Journal of Surgical Research
Verified
Journal Article
Closed access
SSShachi Srivatsa
Shachi Srivatsa
CCCourtney M. Collins
Courtney M. Collins
WKWhitney Kellett
Whitney Kellett
DEDaniel S. Eiferman
Daniel S. Eiferman
JWJon Wisler
Jon Wisler
AJAnahita Jalilvand
Anahita Jalilvand

21 January 2025 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
SSShachi Srivatsa
Shachi Srivatsa
GMGreg Metzger
Greg Metzger
KHKyle Horvath
Kyle Horvath
KPKelli Patterson
Kelli Patterson
MSMegan Scruggs
Megan Scruggs
KSKeri A. Streby
Keri A. Streby
Background: Neuroblastoma is the most common extracranial solid tumor in children, with about half of cases classified as high risk. Treatment varies by risk level, with high‐risk patients undergoing aggressive multimodal therapy. While long‐term survival has improved, survivors face significant risks of late treatment effects, including adrenal insufficiency. This study investigates the incidence of adrenal insufficiency among neuroblastoma patients of varying disease risk.Procedure: This retrospective cohort study at a single tertiary children's hospital reviewed records from 1998 to 2021, identifying 370 neuroblastoma patients, with 137 having complete risk stratification. The primary outcome was the incidence of adrenal insufficiency, diagnosed via clinical evaluation, and compared by risk group.Results: Among 137 patients with neuroblastoma, nine (12.0%) high‐risk and three (4.9%) non‐high‐risk patients were diagnosed with adrenal insufficiency. The cumulative incidence of adrenal insufficiency at 3 years after neuroblastoma diagnosis was 9.9% in high‐risk and 3.5% in non‐high‐risk patients. Among high‐risk neuroblastoma patients with adrenal insufficiency, median time to adrenal insufficiency diagnosis was 10.2 months from neuroblastoma diagnosis, with cases more commonly occurring in patients with adrenal primary tumors (p = 0.0234). There were no other significant differences in demographic or clinical characteristics between high‐risk patients with and without adrenal insufficiency.Conclusions: Adrenal insufficiency occurs more commonly in children with high‐risk neuroblastoma than in non‐high‐risk cases, particularly those with adrenal primary tumors. These findings underscore the need for vigilant monitoring and screening for adrenal insufficiency during and after treatment. Future research should include larger, multi‐institutional cohorts to better understand risk factors and optimize screening protocols.

28 April 2025 in Journal of Pediatric Surgery
Verified
Journal Article
Open access
SSShachi Srivatsa
Shachi Srivatsa
MRMegan Read
Megan Read
BRBrenna Rachwal
Brenna Rachwal
YZYueran Zhang
Yueran Zhang
KGKristine Griffin
Kristine Griffin
Kyle Van ArendonkKyle Van Arendonk
Kyle Van Arendonk
Pyloromyotomy is a clean surgical procedure with a low risk of surgical site infections (SSIs). Despite this, surgical antibiotic prophylaxis (SAP) is often administered, raising concerns about unnecessary antibiotic exposure and antimicrobial resistance. This study aims to evaluate whether SAP reduces SSI rates in infants undergoing pyloromyotomy for hypertrophic pyloric stenosis and to propose a guideline for selective SAP omission. This retrospective cohort study analyzed data from the National Surgical Quality Improvement Program-Pediatric database. Infants undergoing pyloromyotomy between January 1, 2021 and December 31, 2023 were included. The primary outcome was the occurrence of SSIs within 30 days postoperatively. Secondary outcomes included stratified rates of superficial, deep incisional, and organ/space SSIs. Among 4917 infants (age 0.2 for both comparisons). Routine SAP administration in pyloromyotomy is unnecessary given the low risk of SSIs. SAP in ASA Class I or II infants undergoing isolated pyloromyotomy without mucosal perforation, immune-compromising conditions, infections, or trauma should be omitted. These findings support efforts to optimize antibiotic stewardship in pediatric surgical practice. Original Research Article. III.

13 September 2025 in The American Surgeon™
Verified
Journal Article
Closed access
SSShachi Srivatsa
Shachi Srivatsa
MCMehak Chawla
Mehak Chawla
MHMarlene Hernandez
Marlene Hernandez
GMGrace Mallampalli
Grace Mallampalli
ADAngela Duff
Angela Duff
DEDaniel S. Eiferman
Daniel S. Eiferman
Background: Helicopter emergency medical services (HEMS) provide rapid transport for trauma patients to specialized centers, potentially improving outcomes in life-threatening situations. However, HEMS is costly and often overutilized, with limited benefit in low-acuity cases. This study re-evaluates HEMS utilization at our Level I trauma center to assess current appropriateness based on clinical need and validated triage criteria. Methods: We retrospectively analyzed all trauma patients transported to our institution by helicopter from January 2018-December 2021. Patients were categorized into trauma activation criteria and if any procedural intervention was performed within 1 hour of transport. Of the patients that received a procedure during admission, type of procedure and specialty that performed the procedure were evaluated. Disposition from trauma bay was collected. Results: 1419 helicopter transports met inclusion criteria during our analyzed time frame. 37.8% (n = 536) required a procedural intervention during their admission. Only 1.5% of patients (n = 21) who received an intervention were treated within 1 hour of arrival. Less than 30% of patients met criteria for helicopter transport when evaluated with current established national guidelines for prehospital triage. 35% of patients required ICU admission, while 8% were discharged to home within 24 hours. 36.3% (n = 515) of patients were activated as a Level I trauma alert upon arrival. Conclusions: Most helicopter transports were not clinically justified based on urgency or national triage guidelines. These findings highlight persistent overuse of HEMS and reinforce the need for standardized, evidence-based criteria to guide both scene and interfacility helicopter transport decisions in trauma care.